Temozolomide Sensitizes <i>ARID1A</i> -Mutated Cancers to PARP Inhibitors
Zheng-Cheng Yu(Johns Hopkins University), Tian‐Li Wang(Johns Hopkins University)
Cited by 22
Related Papers
Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
|American Journal Of Pathology|2010|185
The Role of Forkhead Box Q1 Transcription Factor in Ovarian Epithelial Carcinomas
|International Journal of Molecular Sciences|2012|30
ARID1A loss activates MAPK signaling via DUSP4 downregulation
|Journal of Biomedical Science|2023|17